Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Leung Chiang

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 27, 2020
Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapyMark Ka Heng Chan, Chi-Leung Chiang
Chinese Clinical Oncology|June 25, 2020
Efficacy and safety of radiotherapy for primary liver cancerWenqi Chen, Chi-Leung Chiang, Laura A Dawson
Radiology|August 27, 2024
Impact of Hepatocellular Carcinoma Etiology on the Performance of LI-RADS LR5Chun Lam Cheung, Vrijesh Tripathi, Chi-Leung Chiang, et al.
Journal of the National Cancer Center|July 22, 2024
The evolving role of radiation therapy as treatment for liver metastasesKhalid Alrabiah, Guixiang Liao, Qi Shen, et al.
Cancers|March 6, 2021
First-Line Atezolizumab Plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma: A Cost-Effectiveness AnalysisChi-Leung Chiang, Sik-Kwan Chan, Shing-Fung Lee, et al.
Prostate Cancer and Prostatic Diseases|July 6, 2019
Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong's perspectiveChi Leung Chiang, Tsz Him So, Tai Chung Lam, et al.
Frontiers in Oncology|June 18, 2024
PD-L1 expression as a potential predictor of immune checkpoint inhibitor efficacy and survival in patients with recurrent or metastatic nasopharyngeal cancer: a systematic review and meta-analysis of prospective trialsRuyu Xu, Charlene H L Wong, Kenneth S K Chan, et al.
Critical Reviews in Oncology/Hematology|July 11, 2025
Efficacy of systemic therapy for advanced hepatocellular carcinoma based on etiology: A systematic review and network meta-analysis of randomized phase III trialsCharlene Hoi Lam Wong, Kenneth Sik Kwan Chan, Regina Cheuk Lam Lo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2026
In Reply to Cao and WangChi Leung Chiang, Kenneth Sik Kwan Chan, Ryo Wan Lung Yeung, et al.
Frontiers in Oncology|December 5, 2019
Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment StrategyChi-Leung Chiang, Albert C Y Chan, Keith W H Chiu, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 27, 2020
Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapyMark Ka Heng Chan, Chi-Leung Chiang
Chinese Clinical Oncology|June 25, 2020
Efficacy and safety of radiotherapy for primary liver cancerWenqi Chen, Chi-Leung Chiang, Laura A Dawson
Radiology|August 27, 2024
Impact of Hepatocellular Carcinoma Etiology on the Performance of LI-RADS LR5Chun Lam Cheung, Vrijesh Tripathi, Chi-Leung Chiang, et al.
Journal of the National Cancer Center|July 22, 2024
The evolving role of radiation therapy as treatment for liver metastasesKhalid Alrabiah, Guixiang Liao, Qi Shen, et al.
Cancers|March 6, 2021
First-Line Atezolizumab Plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma: A Cost-Effectiveness AnalysisChi-Leung Chiang, Sik-Kwan Chan, Shing-Fung Lee, et al.
Prostate Cancer and Prostatic Diseases|July 6, 2019
Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong's perspectiveChi Leung Chiang, Tsz Him So, Tai Chung Lam, et al.
Frontiers in Oncology|June 18, 2024
PD-L1 expression as a potential predictor of immune checkpoint inhibitor efficacy and survival in patients with recurrent or metastatic nasopharyngeal cancer: a systematic review and meta-analysis of prospective trialsRuyu Xu, Charlene H L Wong, Kenneth S K Chan, et al.
Critical Reviews in Oncology/Hematology|July 11, 2025
Efficacy of systemic therapy for advanced hepatocellular carcinoma based on etiology: A systematic review and network meta-analysis of randomized phase III trialsCharlene Hoi Lam Wong, Kenneth Sik Kwan Chan, Regina Cheuk Lam Lo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2026
In Reply to Cao and WangChi Leung Chiang, Kenneth Sik Kwan Chan, Ryo Wan Lung Yeung, et al.
Frontiers in Oncology|December 5, 2019
Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment StrategyChi-Leung Chiang, Albert C Y Chan, Keith W H Chiu, et al.
Pageof 7